Показано 0 из 0
Дата |
---|
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
7.75
|
8.17
|
8.11
|
7.63
|
8.11
|
7.715
|
|
|
135 817.74
|
668.00
|
7.66
|
8.50
|
8.26
|
7.84
|
8.26
|
8.00
|
|
|
328 315.38
|
547.00
|
8.01
|
9.06
|
8.50
|
8.20
|
8.61
|
8.20
|
|
|
148 187.40
|
441.00
|
8.45
|
8.60
|
8.85
|
8.49
|
8.85
|
8.50
|
|
|
176 153.39
|
428.00
|
8.24
|
8.60
|
8.50
|
8.50
|
8.85
|
8.58
|
|
|
70 486.88
|
250.00
|
8.35
|
8.45
|
8.60
|
8.34
|
8.60
|
8.49
|
|
|
104 953.71
|
312.00
|
8.55
|
8.70
|
8.93
|
8.50
|
8.96
|
8.50
|
|
|
443 160.39
|
614.00
|
8.92
|
9.00
|
8.95
|
8.87
|
9.18
|
8.90
|
|
|
310 300.79
|
577.00
|
8.74
|
9.00
|
8.50
|
8.50
|
9.19
|
9.13
|
|
|
151 252.21
|
231.00
|
8.08
|
8.44
|
8.13
|
8.13
|
8.50
|
8.43
|
|
|
133 914.87
|
235.00
|
Outlook Therapeutics, Inc., formerly Oncobiologics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics in immunology and oncology disease areas.